| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 16.56 | -0.02 (-0.11%) | 10.15 - 16.70 | 229.0 thousand (Above Avg) |
Market data as of 3:14PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | 16.57 |
|---|---|
| Previous Close | 16.58 |
| Day's Range | 16.54 - 16.59 |
| Market Cap | 390.5M |
| Avg Volume (10 Day) | 56.5K |
| Price/Earnings (Trailing 12 Mo.) | 23.1x |
| Earnings Per Share (Trailing 12 Mo.) | 0.72 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Pass |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
PR Newswire - Thursday 05/02/2013 1:24 AM ET
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012
PR Newswire - Wednesday 05/01/2013 8:32 AM ET
3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders
PR Newswire - Thursday 04/25/2013 4:30 AM ET
3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction
PR Newswire - Wednesday 04/24/2013 11:53 AM ET
3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders
PR Newswire - Monday 04/22/2013 2:13 PM ET
| SSRX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 24.55% | |
| Net Income Growth (1yr) | -4.51% | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | 4.33% | |
| Price/Sales | 3.43 |
| Company | Last | Change |
|---|---|---|
| Enanta Pharmaceuticals Inc | 20.25 | -2.17% |
| Insmed Inc | 11.46 | -1.46% |
| Cerus Corp | 5.46 | +1.68% |
| GTX Inc | 6.25 | +11.61% |
| Osiris Therapeutics Inc | 10.80 | +0.93% |
Data is delayed by at least 15 min.